The leading workflow platform for increasing the efficiency of gene therapy R&D, Genedata Biologics® supports diverse viral delivery systems including adeno-associated virus (AAV), adenovirus, and retrovirus vectors.
AAVs & Gene Therapies
Genedata Biologics covers the entire gene therapy workflow, from serotype optimization and viral vector design to virus packaging, purification, and testing. It tracks all samples and associated information including customized vectors and packaging plasmids, cell lysates, purified virus batches and their sequences, titers, and assay results such as empty-to-full capsid ratios. Genedata Biologics provides valuable, real-time insights leading to improved quality control, assay standardization, and more accurate viral potency assessments, putting all critical decision factors in one place to facilitate scale-up and reproducibility during vector manufacturing.
We chose Genedata because our teams needed a central, scalable, and robust workflow platform to first collect and track all data across our entire process development organization, and then trace and interpret the data in real-time, facilitating more informed decision-making. Leveraging Genedata’s capabilities will enable us to continue scaling Encoded’s process development capabilities to drive growth and value in gene therapy.
Martin Moorhead, Ph.D., Chief Technology Officer
Assess the results of multiple cell line batches that express CARs in one glance.
In response to a users’ selection, the system automatically displays the relevant regions to be selected to build a new CAR molecule in silico, here it contains two co-stimulatory domains (indicated in orange and light blue).
“Leveraging Genedata’s capabilities will enable us to continue scaling Encoded’s process development capabilities to drive growth and value in gene therapy." Martin Moorhead, Ph.D., Chief Technology Officer